STINGVAX is the first cancer vaccine designed based on STING, containing cancer cells that can secrete granulocyte-macrophage colony-stimulating factor (GM-CSF) and cyclic dinucleotides (CDNs) (Fu et al., 2015). Here, CSF2 is linked to cancer.